Remarkably, IL‐6 modulates glioma characteristics like blockade of sequelae like apoptosis, facilitation of survival, proliferation, angiogenesis, invasiveness, as well as metastasis (Figure 2) [169]. This evidence concerns the gene IL6 and central nervous system cancer.